Polyclonal and Monoclonal Antibodies in Clinic
- 27 August 2013
- book chapter
- Published by Springer Nature
- Vol. 1060, 79-110
Abstract
Immunoglobulins (Ig) or antibodies are heavy plasma proteins, with sugar chains added to amino-acid residues by N-linked glycosylation and occasionally by O-linked glycosylation. The versatility of antibodies is demonstrated by the various functions that they mediate such as neutralization, agglutination, fixation with activation of complement and activation of effector cells. Naturally occurring antibodies protect the organism against harmful pathogens, viruses and infections. In addition, almost any organic chemical induces antibody production of antibodies that would bind specifically to the chemical. These antibodies are often produced from multiple B cell clones and referred to as polyclonal antibodies. In recent years, scientists have exploited the highly evolved machinery of the immune system to produce structurally and functionally complex molecules such as antibodies from a single B clone, heralding the era of monoclonal antibodies. Most of the antibodies currently in the clinic, target components of the immune system, are not curative and seek to alleviate symptoms rather than cure disease. Our group used a novel strategy to identify reparative human monoclonal antibodies distinct from conventional antibodies. In this chapter, we discuss the therapeutic relevance of both polyclonal and monoclonal antibodies in clinic.Keywords
This publication has 196 references indexed in Scilit:
- BelimumabNature Reviews Drug Discovery, 2011
- Treatment with Natalizumab in Relapsing–Remitting Multiple Sclerosis Patients Induces Changes in Inflammatory MechanismJournal of Clinical Immunology, 2011
- Human remyelination promoting antibody inhibits apoptotic signaling and differentiation through Lyn kinase in primary rat oligodendrocytesGlia, 2010
- Primary immunodeficienciesJournal of Allergy and Clinical Immunology, 2010
- Cellular Mechanisms of Central Nervous System Repair by Natural Autoreactive Monoclonal AntibodiesArchives of Neurology, 2009
- Ranibizumab for Neovascular Age-Related Macular DegenerationNew England Journal of Medicine, 2006
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancerNature Reviews Drug Discovery, 2004
- Effect of high doses of intravenously administered immune globulin on natural killer cell activity in peripheral bloodThe Journal of Pediatrics, 1992
- Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxinThe Journal of Pediatrics, 1991
- Anticytotoxin-neutralizing antibodies in immune globulin preparations: Potential use in hemolytic-uremic syndromeThe Journal of Pediatrics, 1988